SARS-CoV-2 is associated to a severe respiratory disease in China, that rapidly spread across continents. Since the beginning of the pandemic, available data suggested the asymptomatic transmission and patients were treated with specific drugs with efficacy and safety data not always satisfactory.
Vaccine development and technology for SARS-CoV-2: current insights
Cattel, Luigi;Giordano, Susanna;Traina, Sara;Lupia, Tommaso;Corcione, Silvia;La Valle, Giovanni;De Rosa, Francesco Giuseppe;Cattel, Francesco
2022-01-01
Abstract
SARS-CoV-2 is associated to a severe respiratory disease in China, that rapidly spread across continents. Since the beginning of the pandemic, available data suggested the asymptomatic transmission and patients were treated with specific drugs with efficacy and safety data not always satisfactory.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
JMV-94-878.pdf
Accesso aperto
Descrizione: Vaccine development and technology for SARS‐CoV‐2: Current insight
Tipo di file:
PDF EDITORIALE
Dimensione
2.19 MB
Formato
Adobe PDF
|
2.19 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
